Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
BJDX Bluejay Diagnostics
- 3.9800
- -0.2400-5.69%
Close Feb 26 16:00 ET
- 4.2000
- +0.2200+5.53%
Pre 08:05 ET
2.20MMarket Cap0.00P/E (TTM)
4.2000High3.5800Low107.21KVolume3.9500Open4.2200Pre Close421.05KTurnover68.63%Turnover Ratio0.00P/E (Static)552.85KShares386.720052wk High0.31P/B621.71KFloat Cap3.030052wk Low--Dividend TTM156.21KShs Float50000.0000Historical High--Div YieldTTM14.69%Amplitude3.0300Historical Low3.9270Avg Price1Lot Size
Bluejay Diagnostics News
Bluejay Diagnostics | SCHEDULE 13G/A: Others
Bluejay Diagnostics | SCHEDULE 13G/A: Others
Bluejay Diagnostics | SCHEDULE 13G/A: Others
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(5.1%),Anson Management GP LLC(5.1%), etc.
Bluejay Diagnostics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Bluejay Diagnostics | 10-Q: Q3 2024 Earnings Report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | DEFA14A: Others
Bluejay Diagnostics | DEF 14A: Definitive information statements
Bluejay Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 10-Q: Q2 2024 Earnings Report
Bluejay Diagnostics | DEF 14A: Definitive information statements
Bluejay Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Bluejay Diagnostics | SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(9.99%)
Bluejay Diagnostics | 8-K: Current report